Citations (81)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ziwen Ma, Liming Chu, Yan Zhang, Fang Lu, Yun Zhu, Fei Wu & Zhiping Zhang. (2023) Is Chemerin Associated with Gestational Diabetes Mellitus? A Case-Control Study. Diabetes, Metabolic Syndrome and Obesity 16, pages 2271-2281.
Read now
Read now
Xin Huang, Changhong Chen, Yaofei Chen, Jun Xu & Lin Liu. (2022) Omentin-1 alleviate interleukin-1β(IL-1β)-induced nucleus pulposus cells senescence. Bioengineered 13:5, pages 13849-13859.
Read now
Read now
Mohamed Abdelraouf Korany, Ahmed Sonbol & Sameh Mohamed Elgouhary. (2018) Omentin-1 and diabetic retinopathy in type 2 diabetic patients. Alexandria Journal of Medicine 54:4, pages 323-326.
Read now
Read now
Farzad Zehsaz, Negin Farhangi & Mehri Ghahramani. (2016) The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity. The Physician and Sportsmedicine 44:4, pages 355-361.
Read now
Read now
Samad Akbarzadeh, Fatemeh Eskandari, Hadis Tangestani, Somaieh Tangerami Bagherinejad, Afshar Bargahi, Parviz Bazzi, Adel Daneshi, Azam Sahrapoor, William J. O'Connor & Ali Reza Rahbar. (2015) The Effect of Stevia Rebaudiana on Serum Omentin and Visfatin Level in STZ-Induced Diabetic Rats. Journal of Dietary Supplements 12:1, pages 11-22.
Read now
Read now
Eda Celik Guzel, Cem Celik, Remzi Abali, Volkan Kucukyalcin, Elcin Celik, Murat Guzel & Murat Yilmaz. (2014) Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecological Endocrinology 30:6, pages 419-422.
Read now
Read now
Erkan Sengul, Gokhan Duygulu, Sevim Dindar & Fatih Bunul. (2013) Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Renal Failure 35:8, pages 1089-1093.
Read now
Read now
Martti Färkkilä. (2011) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:1, pages 3-5.
Read now
Read now
Aida A. Hussein, Noha A. Ahmed, Hader I. Sakr, Tarek Atia & Osama M. Ahmed. Omentin roles in physiology and pathophysiology: an up-to-date comprehensive review. Archives of Physiology and Biochemistry 0:0, pages 1-14.
Read now
Read now
Articles from other publishers (72)
Filiz Guclu-Geyik, Pınar Koseoglu, Gamze Guven, Gunay Can, Aysem Kaya, Neslihan Coban, Evrim Komurcu-Bayrak & Nihan Erginel-Unaltuna. (2023) Association of Intelectin 1 Gene rs2274907 A > T Polymorphism with Obesity, Type 2 Diabetes, Serum Intelectin-1 Levels and Lipid Profiles in Turkish Adults. Biochemical Genetics 61:6, pages 2276-2292.
Crossref
Crossref
Mona A. El-Bana, Magdi N. Ashour, Wafaa I. Rasheed, Yasser M. Diab & Dalia Medhat. (2023)
Bombax ceiba
Linn. leaf extract rich in phenolic compounds to mitigate non-alcoholic fatty liver-related complications in experimental model
. Journal of Complementary and Integrative Medicine 20:2, pages 343-352.
Crossref
Crossref
Maria Magdalena Quetglas-Llabrés, Margalida Monserrat-Mesquida, Cristina Bouzas, Isabel Llompart, David Mateos, Miguel Casares, Lucía Ugarriza, J. Alfredo Martínez, Josep A. Tur & Antoni Sureda. (2023) Mediterranean Diet Improves Plasma Biomarkers Related to Oxidative Stress and Inflammatory Process in Patients with Non-Alcoholic Fatty Liver Disease. Antioxidants 12:4, pages 833.
Crossref
Crossref
Mohsen Rastkar, Leila Nikniaz, Mahdieh Abbasalizad Farhangi & Zeinab Nikniaz. (2023) Circulating chemerin level and the risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. Journal of Diabetes & Metabolic Disorders 22:1, pages 83-95.
Crossref
Crossref
Jianbo Zhao, Yafei Wu, Peng Lu, Xiaoqin Wu, Junming Han, Yingzhou Shi, Yue Liu, Yiping Cheng, Ling Gao, Jiajun Zhao, Zhen Wang & Xiude Fan. (2022) Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis. Frontiers in Immunology 13.
Crossref
Crossref
Qian Ren, Hongya Wang, Yan Zeng, Xia Fang, Mei Wang, Dongze Li, Wei Huang & Yong Xu. (2022) Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis. Lipids in Health and Disease 21:1.
Crossref
Crossref
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Taruna Arora, Nalini Moza Wali & Archana Burman. (2022) Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma. Journal of Cellular Biochemistry 123:10, pages 1553-1584.
Crossref
Crossref
Vladimir V. Salukhov, Yaroslav R. Lopatin & Alexey A. Minakov. (2022) Adipsin – summing up large-scale results: A review. Consilium Medicum 24:5, pages 317-323.
Crossref
Crossref
Maria Petrescu, Sonia Irina Vlaicu, Lorena Ciumărnean, Mircea Vasile Milaciu, Codruța Mărginean, Mira Florea, Ștefan Cristian Vesa & Monica Popa. (2022) Chronic Inflammation—A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. Medicina 58:5, pages 641.
Crossref
Crossref
Josh Bilson, Jaswinder K. Sethi & Christopher D. Byrne. (2021) Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of the Nutrition Society 81:2, pages 146-161.
Crossref
Crossref
Esra Akyüz Özkan, Allahverdi Sadigov & Osman Öztürk. (2022) Evaluation of Serum Omentin-1, Vaspin, Leptin, Adiponectin Levels in Obese/Overweight Children and Their Relationship With Non-Alcoholic Fatty Liver Disease. Clinical Nutrition Research 11:3, pages 194.
Crossref
Crossref
Yingying Gu, Jing Luo, Qian Chen, Yun Qiu, Yujia Zhou, Xu Wang, Xiaoyun Qian, Yao Liu, Jiewen Xie, Zhongliang Xu, Wenhua Ling, Yuming Chen & Lili Yang. (2022) Inverse Association of Serum Adipsin with the Remission of Nonalcoholic Fatty-Liver Disease: A 3-Year Community-Based Cohort Study. Annals of Nutrition and Metabolism 78:1, pages 21-32.
Crossref
Crossref
Afsoon Daneshafrooz, Emad Yuzbashian, Maryam Zarkesh, Golaleh Asghari, Parvin Mirmiran, Mehdi Hedayati, Raziyeh Abooshahab, S. Melika Fanaei & Alireza Khalaj. (2021) The relation of omentin gene expression and glucose homeostasis of visceral and subcutaneous adipose tissues in non-diabetic adults. Molecular Biology Reports 49:1, pages 163-169.
Crossref
Crossref
Jinhua Zhang, Kangli Li, Lingling Pan, Fei Teng, Peizhen Zhang, Bingquan Lin, Youwen Yuan, Xueyun Wei, Wenyuan Li & Huijie Zhang. (2021) Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study. BMC Gastroenterology 21:1.
Crossref
Crossref
Emine Turkkan, Huseyin Dag, Okan Dikker, Nevin Cetin Dag, Alper Kacar & Soner Sazak. (2021) Omentin-1 Levels and Non-alcoholic Fatty Liver Disease in Obese Adolescents. Iranian Journal of Pediatrics 31:5.
Crossref
Crossref
Ozlem Kucukoglu, Jan-Peter Sowa, Guillermo Daniel Mazzolini, Wing-Kin Syn & Ali Canbay. (2021) Hepatokines and adipokines in NASH-related hepatocellular carcinoma. Journal of Hepatology 74:2, pages 442-457.
Crossref
Crossref
Mayu Kyohara, Jun Shirakawa, Tomoko Okuyama, Yu Togashi, Ryota Inoue, Jinghe Li, Daisuke Miyashita & Yasuo Terauchi. (2020) Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects. Diabetology & Metabolic Syndrome 12:1.
Crossref
Crossref
Jung A. Kim & Kyung Mook Choi. (2020) Newly Discovered Adipokines: Pathophysiological Link Between Obesity and Cardiometabolic Disorders. Frontiers in Physiology 11.
Crossref
Crossref
Fatma Betül Guzel, Orcun Altunoren, Hakan Gunes, Muhammed Seyithanoglu, Murat Kerkutluoglu, Didem Tutuncu Sezal & Ozkan Gungor. (2020) The relation between epicardial fat tissue thickness and atrial fibrillation ın hemodialysis patients. Seminars in Dialysis 33:5, pages 428-434.
Crossref
Crossref
Damian Jacenik & Jakub Fichna. (2020) Chemerin in immune response and gastrointestinal pathophysiology. Clinica Chimica Acta 504, pages 146-153.
Crossref
Crossref
Artur Borowski & Lucyna Siemińska. (2020) Serum Omentin Levels in Patients with Prostate Cancer and Associations with Sex Steroids and Metabolic Syndrome. Journal of Clinical Medicine 9:4, pages 1179.
Crossref
Crossref
Azimeh Izadi, Fereshteh Aliasghari, Bahram Pourghassem Gargari & Sara Ebrahimi. (2020) Strong association between serum Vitamin D and Vaspin Levels, AIP, VAI and liver enzymes in NAFLD patients. International Journal for Vitamin and Nutrition Research 90:1-2, pages 59-66.
Crossref
Crossref
Marta Olivera-Santa Catalina, Pedro C. Redondo, Maria P. Granados, Carlos Cantonero, Jose Sanchez-Collado, Letizia Albarran & Jose J. Lopez. (2019) New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus. Current Medicinal Chemistry 26:22, pages 4119-4144.
Crossref
Crossref
Fereshteh Aliasghari, Azimeh Izadi, Masoumeh Jabbari, Bahareh Imani, Bahram Pourghassem Gargari, Foad Asjodi & Sara Ebrahimi. (2018) Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients?. Journal of Medical Biochemistry 37:4, pages 470-475.
Crossref
Crossref
Zhongwei Zhou, Hongmei Chen, Huixiang Ju & Mingzhong Sun. (2018) Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis. Lipids in Health and Disease 17:1.
Crossref
Crossref
Petra Niklowitz, Juliane Rothermel, Nina Lass, Andre Barth & Thomas Reinehr. (2018) Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention. International Journal of Obesity 42:10, pages 1743-1752.
Crossref
Crossref
Qing Zhou, Qian Ge, Yao Ding, Hua Qu, Huili Wei, Rui Wu, Lu Yao, Qianping Wei, Zhengping Feng, Jian Long & Huacong Deng. (2018) Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance. Journal of Diabetes Investigation 9:5, pages 1128-1134.
Crossref
Crossref
Yan Zhou, Bo Zhang, Caixia Hao, Xiaoting Huang, Xiaohong Li, Yanhong Huang & Ziqiang Luo. (2017) Omentin-A Novel Adipokine in Respiratory Diseases. International Journal of Molecular Sciences 19:1, pages 73.
Crossref
Crossref
Marta Sledzińska, Agnieszka Szlagatys-Sidorkiewicz, Michał Brzezinski, Katarzyna Kaźmierska, Tomasz Sledziński & Barbara Kamińska. (2017) Serum chemerin in children with excess body weight may be associated with ongoing metabolic complications – A pilot study. Advances in Medical Sciences 62:2, pages 383-386.
Crossref
Crossref
Zhigang Li, Baoyi Liu, Dewei Zhao, BenJie Wang, Yupeng Liu, Yao Zhang, Borui Li & Fengde Tian. (2017) Omentin-1 prevents cartilage matrix destruction by regulating matrix metalloproteinases. Biomedicine & Pharmacotherapy 92, pages 265-269.
Crossref
Crossref
Timon Adolph, Christoph Grander, Felix Grabherr & Herbert Tilg. (2017) Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. International Journal of Molecular Sciences 18:8, pages 1649.
Crossref
Crossref
Kaushik Patnaik, A. R. Pradeep, Kanika Nagpal, Shruti Karvekar, Priyanka Singh & Arjun Raju. (2017) Human chemerin correlation in gingival crevicular fluid and tear fluid as markers of inflammation in chronic periodontitis and type-2 diabetes mellitus. Journal of Investigative and Clinical Dentistry 8:1, pages e12181.
Crossref
Crossref
Manuela G. Neuman, Samuel W. French, Samir Zakhari, Stephen Malnick, Helmut K. Seitz, Lawrence B Cohen, Mikko Salaspuro, Andreea Voinea-Griffin, Andrei Barasch, Irina A. Kirpich, Paul G. Thomes, Laura W. Schrum, Terrence M. DonohueJr.Jr., Kusum K. Kharbanda, Marcus Cruz & Mihai Opris. (2017) Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage. Experimental and Molecular Pathology 102:1, pages 162-180.
Crossref
Crossref
Michał Kukla, Marek Waluga, Michał Żorniak, Agnieszka Berdowska, Piotr Wosiewicz, Tomasz Sawczyn, Rafał J Bułdak, Marek Ochman, Katarzyna Ziora, Tadeusz Krzemiński & Marek Hartleb. (2017) Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World Journal of Gastroenterology 23:14, pages 2613.
Crossref
Crossref
Rebekka Pohl, Elisabeth M. Haberl, Lisa Rein-Fischboeck, Sebastian Zimny, Maximilian Neumann, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Kristina Eisinger, Thomas S. Weiss & Christa Buechler. (2017) Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. European Journal of Clinical Investigation 47:1, pages 7-18.
Crossref
Crossref
Marlies Bekaert, D. Margriet Ouwens, Tina Hörbelt, Frederique Van de Velde, Pia Fahlbusch, Daniella Herzfeld de Wiza, Yves Van Nieuwenhove, Patrick Calders, Marleen Praet, Anne Hoorens, Anja Geerts, Xavier Verhelst, Jean-Marc Kaufman & Bruno Lapauw. (2016) Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity. Obesity 24:12, pages 2544-2552.
Crossref
Crossref
Stergios A. Polyzos, Jannis Kountouras & Christos S. Mantzoros. (2016) Adipokines in nonalcoholic fatty liver disease. Metabolism 65:8, pages 1062-1079.
Crossref
Crossref
Sinan İnci, Gökhan Aksan & Pınar Doğan. (2016) Chemerin as an independent predictor of cardiovascular event risk. Therapeutic Advances in Endocrinology and Metabolism 7:2, pages 57-68.
Crossref
Crossref
Ki-Yong Ahn, Mi Kyung Lee, Dong-Il Kim, Jihye Park, Jihee Min, Hyuk In Yang, Junga Lee, Minsuk Oh, Joongbae An, Ji-Won Lee, Sang Hui Chu, Jeffrey A. Meyerhardt, Nam-Kyu Kim & Justin Y. Jeon. (2016) Cardiopulmonary fitness, adiponectin, chemerin associated fasting insulin level in colorectal cancer patients. Supportive Care in Cancer.
Crossref
Crossref
Huadong LiuWei XiongQiyun LiuJian ZhangShaohong Dong. (2016) Chemokine-Like Receptor 1 Regulates the Proliferation and Migration of Vascular Smooth Muscle Cells. Medical Science Monitor 22, pages 4054-4061.
Crossref
Crossref
M. Bekaert, X. Verhelst, A. Geerts, B. Lapauw & P. Calders. (2015) Association of recently described adipokines with liver histology in biopsy‐proven non‐alcoholic fatty liver disease: a systematic review. Obesity Reviews 17:1, pages 68-80.
Crossref
Crossref
Mélodie Diot, Maxime Reverchon, Christelle Rame, Pascal Froment, Jean-Pierre Brillard, Sylvain Brière, Gérard Levêque, Daniel Guillaume & Joëlle Dupont. (2015) Expression of adiponectin, chemerin and visfatin in plasma and different tissues during a laying season in turkeys. Reproductive Biology and Endocrinology 13:1.
Crossref
Crossref
Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang & Ji-Oh Mok. (2015) Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study. Cardiovascular Diabetology 14:1.
Crossref
Crossref
J Lesná, A Tichá, R Hyšpler, F Musil, V Bláha, L Sobotka, Z Zadák & A Šmahelová. (2015) Omentin-1 plasma levels and cholesterol metabolism in obese patients with diabetes mellitus type 1: impact of weight reduction. Nutrition & Diabetes 5:11, pages e183-e183.
Crossref
Crossref
Karla Bianca NevesAurelie Nguyen Dinh CatRheure Alves Moreira LopesFrancisco Jose RiosAikaterini AnagnostopoulouNubia Souza LobatoAna Maria de OliveiraRita C. TostesAugusto C. MontezanoRhian M. Touyz. (2015) Chemerin Regulates Crosstalk Between Adipocytes and Vascular Cells Through Nox. Hypertension 66:3, pages 657-666.
Crossref
Crossref
Ping Gu, Maowei Cheng, Xiaoyan Hui, Bin Lu, Weimin Jiang & Zhaorong Shi. (2015) Elevating circulation chemerin level is associated with endothelial dysfunction and early atherosclerotic changes in essential hypertensive patients. Journal of Hypertension 33:8, pages 1624-1632.
Crossref
Crossref
Yu-Lin Tan, Xi-Long Zheng & Chao-Ke Tang. (2015) The protective functions of omentin in cardiovascular diseases. Clinica Chimica Acta 448, pages 98-106.
Crossref
Crossref
Erifili Hatziagelaki, Christian Herder, Anastasia Tsiavou, Tom Teichert, Athina Chounta, Peter Nowotny, Giovanni Pacini, George Dimitriadis & Michael Roden. (2015) Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD). PLOS ONE 10:5, pages e0124935.
Crossref
Crossref
Kristina Eisinger, Sabrina Krautbauer, Reiner Wiest, Thomas S. Weiss & Christa Buechler. (2015) Reduced serum chemerin in patients with more severe liver cirrhosis. Experimental and Molecular Pathology 98:2, pages 208-213.
Crossref
Crossref
Jing He, Ji-Chun Li, Hua Xie, Zhong-Hua Xu, Ya-Wen Sun & Qiao Shan. (2015) Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Disease Markers 2015, pages 1-6.
Crossref
Crossref
Monika Kłusek-Oksiuta, Irena Bialokoz-Kalinowska, Eugeniusz Tarasów, Malgorzata Wojtkowska, Irena Werpachowska & Dariusz Marek Lebensztejn. (2014) Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children. Italian Journal of Pediatrics 40:1.
Crossref
Crossref
E. Hertle, C.D.A. Stehouwer & M.M.J. van Greevenbroek. (2014) The complement system in human cardiometabolic disease. Molecular Immunology 61:2, pages 135-148.
Crossref
Crossref
Vasiliki Katsi, Georgia Vamvakou, John Lekakis, Dimitris Tousoulis, Christodoulos Stefanadis, Thomas Makris & Ioannis Kallikazaros. (2014) Omentin, Fat and Heart: Classical Music with New Instruments. Heart, Lung and Circulation 23:9, pages 802-806.
Crossref
Crossref
Kenji Imai, Koji Takai, Tatsunori Hanai, Makoto Shiraki, Yusuke Suzuki, Hideki Hayashi, Takafumi Naiki, Youichi Nishigaki, Eiichi Tomita, Masahito Shimizu & Hisataka Moriwaki. (2014) Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma. International Journal of Molecular Sciences 15:7, pages 11294-11306.
Crossref
Crossref
S. K. Malin, S. D. Navaneethan, A. Mulya, H. Huang & John P. Kirwan. (2014) Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults. The journal of nutrition, health & aging 18:6, pages 608-615.
Crossref
Crossref
Henrike Sell & Christine Poitou. (2014) La chémérine : une adipokine pro-inflammatoire impliquée dans les maladies métaboliques. Cahiers de Nutrition et de Diététique 49:2, pages 88-92.
Crossref
Crossref
Zi Ye, Suijun Wang, Zhen Yang, Min He, Shuo Zhang, Weiwei Zhang, Jie Wen, Qin Li, Ying Huang, Xuanchun Wang, Bin Lu, Zhaoyun Zhang, Qing Su & Renming Hu. (2014) Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Molecular Biology Reports 41:3, pages 1317-1323.
Crossref
Crossref
Stergios A. Polyzos, Jannis Kountouras, Athanasios D. Anastasilakis, Eleni V. Geladari & Christos S. Mantzoros. (2014) Irisin in patients with nonalcoholic fatty liver disease. Metabolism 63:2, pages 207-217.
Crossref
Crossref
Michał Kukla, Brygida Adamek, Marek Waluga, Marzena Zalewska-Ziob, Janusz Kasperczyk, Andrzej Gabriel, Włodzimierz Mazur, Barbara Sobala-Szczygieł, Rafał J. Bułdak, Wojciech Zajęcki, Lucjan Kępa, Katarzyna Ziora, Krystyna Żwirska-Korczala, Andrzej Wiczkowski & Marek Hartleb. (2014)
Hepatic
Chemerin
and
Chemokine-Like Receptor 1
Expression in Patients with Chronic Hepatitis C
. BioMed Research International 2014, pages 1-12.
Crossref
Crossref
S Döcke, J F Lock, A L Birkenfeld, S Hoppe, S Lieske, A Rieger, N Raschzok, I M Sauer, S Florian, M A Osterhoff, R Heller, K Herrmann, S Lindenmüller, P Horn, M Bauer, M O Weickert, P Neuhaus, M Stockmann, M Möhlig, A F H Pfeiffer & C von Loeffelholz. (2013) Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease. European Journal of Endocrinology 169:5, pages 547-557.
Crossref
Crossref
Sabrina Krautbauer, Josef Wanninger, Kristina Eisinger, Yvonne Hader, Michael Beck, Andrea Kopp, Andreas Schmid, Thomas S. Weiss, Christoph Dorn & Christa Buechler. (2013) Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver. Experimental and Molecular Pathology 95:2, pages 199-205.
Crossref
Crossref
Giuseppe DerosaArrigo F.G. CiceroIvano G. FranzettiFabrizio QuerciAnna CarboneLeonardina CiccarelliAngela D’AngeloElena FogariPamela Maffioli. (2013) Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy. Canadian Journal of Physiology and Pharmacology 91:9, pages 724-732.
Crossref
Crossref
Kristina Eisinger, Sabrina Krautbauer, Reiner Wiest, Thomas Karrasch, Yvonne Hader, Marcus N. Scherer, Stefan Farkas, Charalampos Aslanidis & Christa Buechler. (2013) Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension. European Journal of Clinical Investigation 43:9, pages 926-932.
Crossref
Crossref
J. L. Rourke, H. J. Dranse & C. J. Sinal. (2012) Towards an integrative approach to understanding the role of chemerin in human health and disease. Obesity Reviews 14:3, pages 245-262.
Crossref
Crossref
Alireza Esteghamati, Sina Noshad, Soghra Rabizadeh, Mojgan Ghavami, Ali Zandieh & Manouchehr Nakhjavani. (2013) Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial. Regulatory Peptides 182, pages 1-6.
Crossref
Crossref
Marc Parmentier. 2013. Handbook of Biologically Active Peptides. Handbook of Biologically Active Peptides
649
655
.
Yusuf Yilmaz & Fatih Eren. (2012) Identification of a support vector machine-based biomarker panel with high sensitivity and specificity for nonalcoholic steatohepatitis. Clinica Chimica Acta 414, pages 154-157.
Crossref
Crossref
Sang Hui Chu, Mi Kyung Lee, Ki Yong Ahn, Jee-Aee Im, Min Soo Park, Duk-Chul Lee, Justin Y. Jeon & Ji Won Lee. (2012) Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome. PLoS ONE 7:4, pages e34710.
Crossref
Crossref
Benjamin Bondue, Valérie Wittamer & Marc Parmentier. (2011) Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & Growth Factor Reviews 22:5-6, pages 331-338.
Crossref
Crossref
Anna Prats‐Puig, Judit Bassols, Eva Bargalló, Marta Mas‐Parareda, Rosa Ribot, Pilar Soriano‐Rodríguez, Àngela Berengüí, Marta Díaz, Francis de Zegher, Lourdes Ibánez & Abel López‐Bermejo. (2012) Toward an Early Marker of Metabolic Dysfunction: Omentin‐1 in Prepubertal Children. Obesity 19:9, pages 1905-1907.
Crossref
Crossref
Yusuf Yilmaz, Ramazan Kurt, Ahmet Gurdal, Yesim Ozen Alahdab, Oya Yonal, Ebubekir Senates, Nihat Polat, Fatih Eren, Nese Imeryuz & Huseyin Oflaz. (2011) Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 217:1, pages 125-129.
Crossref
Crossref
Bee K. Tan, Raghu Adya & Harpal S. Randeva. (2010) Omentin: A Novel Link Between Inflammation, Diabesity, and Cardiovascular Disease. Trends in Cardiovascular Medicine 20:5, pages 143-148.
Crossref
Crossref